I 

117TH CONGRESS 

1ST SESSION H. R. 1193 

To amend title IV of the Public Health Service Act to direct the Director 

of the National Institutes of Health, in consultation with the Director 

of the National Heart, Lung, and Blood Institute, shall establish a 

program under which the Director of the National Institutes of Health 

shall support or conduct research on valvular heart disease, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 22, 2021 

Mr. BARR introduced the following bill; which was referred to the Committee 

on Energy and Commerce 

A BILL 

To amend title IV of the Public Health Service Act to 

direct the Director of the National Institutes of Health, 

in consultation with the Director of the National Heart, 

Lung, and Blood Institute, shall establish a program 

under which the Director of the National Institutes of 

Health shall support or conduct research on valvular 

heart disease, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•HR 1193 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Cardiovascular Ad3 vances in Research and Opportunities Legacy Act’’. 

4 SEC. 2. GRANTS FOR VALVULAR HEART DISEASE RE5 SEARCH. 

6 Subpart 2 of part C of title IV of the Public Health 

7 Service Act (42 U.S.C. 285b et seq.) is amended by insert8 ing after section 424C (42 U.S.C. 285b–7c) the following: 

9 ‘‘SEC. 424D. GRANTS FOR VALVULAR HEART DISEASE RE10 SEARCH. 

11 ‘‘(a) IN GENERAL.—The Director of the National In12 stitutes of Health, in consultation with the Director of the 

13 Institute, shall support or conduct research regarding val14 vular heart disease. 

15 ‘‘(b) SUPPORT GUIDELINES.—The distribution of 

16 funding authorized in subsection (a) may be used to pur17 sue the following outcomes— 

18 ‘‘(1) using precision medicine and advanced 

19 technological imaging to generate data on individ20 uals with valvular heart disease; 

21 ‘‘(2) identifying and developing a cohort of indi22 viduals with valvular heart disease and available 

23 data; 

24 ‘‘(3) corroborating data generated through clin25 ical trials to develop a prediction model to distin26 guish individuals at high risk for sudden cardiac arVerDate Sep 11 2014 22:16 Apr 01, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1193.IH H1193

pbinns on DSKJLVW7X2PROD with BILLS
3 

•HR 1193 IH

1 rest or sudden cardiac death from valvular heart dis2 ease; or 

3 ‘‘(4) for other outcomes needed to acquire nec4 essary data on valvular heart disease. 

5 ‘‘(c) MITRAL VALVE PROLAPSE WORKSHOP.—Not 

6 later than one year after the date of the enactment of this 

7 section, the Director of the Institute shall convene a work8 shop composed of subject matter experts and stakeholders 

9 to identify research needs and opportunities to develop 

10 prescriptive guidelines for treatment of individuals with 

11 mitral valve prolapse. 

12 ‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the 

13 purpose of carrying out this section, there is authorized 

14 to be appropriated $20,000,000 for each of fiscal years 

15 2022 through 2026.’’. 

16 SEC. 3. PROGRAMS OF CENTERS FOR DISEASE CONTROL 

17 AND PREVENTION. 

18 Part J of title III of the Public Health Service Act 

19 (42 U.S.C. 2 et seq.) is amended by inserting after section 

20 393 the following section: 

21 ‘‘SEC. 393A. PREVENTION OF SUDDEN CARDIAC DEATH AS A 

22 RESULT OF VALVULAR HEART DISEASE. 

23 ‘‘(a) IN GENERAL.—The Secretary, acting through 

24 the Director of the Centers for Disease Control and Pre25 vention, may carry out projects to increase education, 


pbinns on DSKJLVW7X2PROD with BILLS
4 

•HR 1193 IH

1 awareness or diagnosis of valvular heart disease and to 

2 reduce the incidence of sudden cardiac death caused by 

3 valvular heart disease. Such projects may be carried out 

4 by the Secretary directly or through awards of grants or 

5 contracts to public or nonprofit private entities. The Sec6 retary may directly (or through such awards) provide tech7 nical assistance with respect to the planning, development, 

8 and operation of such projects. 

9 ‘‘(b) CERTAIN ACTIVITIES.—Projects carried out 

10 under subsection (a) may include— 

11 ‘‘(1) the implementation of public information 

12 and education programs for— 

13 ‘‘(A) the prevention of sudden cardiac 

14 death from valvular heart disease; 

15 ‘‘(B) broadening the awareness of the pub16 lic concerning the risk factors for, the symp17 toms of, and the public health consequences of 

18 valvular heart disease; and 

19 ‘‘(C) increasing screening, detection, and 

20 diagnosis of valvular heart disease; and 

21 ‘‘(2) surveillance of out of hospital cardiac ar22 rests to improve patient outcomes. 

23 ‘‘(c) GRANT PRIORITIZATION.—The Secretary may, 

24 in awarding grants or entering into contracts pursuant to 

25 subsection (a), give priority to entities seeking to carry 


pbinns on DSKJLVW7X2PROD with BILLS
5 

•HR 1193 IH

1 out projects that target populations most impacted by val2 vular heart disease. 

3 ‘‘(d) COORDINATION OF ACTIVITIES.—The Secretary 

4 shall ensure that activities under this section are coordi5 nated, as appropriate, with other agencies of the Public 

6 Health Service that carry out activities regarding valvular 

7 heart disease. 

8 ‘‘(e) BEST PRACTICES.—The Secretary, acting 

9 through the Director of the Centers for Disease Control 

10 and Prevention, shall— 

11 ‘‘(1) collect and analyze the findings of research 

12 conducted with respect to valvular heart disease; and 

13 ‘‘(2) taking into account such findings, publish 

14 on the website of the Centers for Disease Control 

15 and Prevention best practices for physicians and 

16 other health care providers who provide care to indi17 viduals with valvular heart disease. 

18 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—For the 

19 purpose of carrying out this section, there is authorized 

20 to be appropriated such sums as may be necessary for 

21 each of fiscal years 2022 through 2026.’’. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS